Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma (2023)
- Authors:
- USP affiliated authors: XAVIER, ANA CLAUDIA LATRÔNICO - FM ; MENDONÇA, BERENICE BILHARINHO DE - FM
- Unidade: FM
- DOI: 10.1210/clinem/dgad028
- Subjects: FEOCROMOCITOMA; BRASILEIROS; METÁSTASE NEOPLÁSICA; MUTAÇÃO GENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2023
- Source:
- Título do periódico: Journal of clinical endocrinology & metabolism
- ISSN: 0021-972X
- Volume/Número/Paginação/Ano: v. 108, n. 8, p. 2105-2114, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FAGUNDES, Gustavo F. C et al. Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma. Journal of clinical endocrinology & metabolism, v. 108, n. 8, p. 2105-2114, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54605. Acesso em: 11 jun. 2024. -
APA
Fagundes, G. F. C., Freitas-Castro, F., Santana, L. S., Afonso, A. C. F., Petenuci, J., Funari, M. F. A., et al. (2023). Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma. Journal of clinical endocrinology & metabolism, 108( 8), 2105-2114. doi:10.1210/clinem/dgad028 -
NLM
Fagundes GFC, Freitas-Castro F, Santana LS, Afonso ACF, Petenuci J, Funari MFA, Guimaraes AG, Ledesma FL, Xavier ACL, Mendonca BB de. Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma [Internet]. Journal of clinical endocrinology & metabolism. 2023 ; 108( 8): 2105-2114.[citado 2024 jun. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54605 -
Vancouver
Fagundes GFC, Freitas-Castro F, Santana LS, Afonso ACF, Petenuci J, Funari MFA, Guimaraes AG, Ledesma FL, Xavier ACL, Mendonca BB de. Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma [Internet]. Journal of clinical endocrinology & metabolism. 2023 ; 108( 8): 2105-2114.[citado 2024 jun. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54605 - Update on the etiology, diagnosis and therapeutic management of sexual precocity
- A novel missense variant in the Necdin gene in a male patient with kallmann syndrome
- Localization of Occult Adrenal Tissue with Cosyntropin-Stimulated 18F-FDG-PET/CT in a Patient with Metachronous Adrenocortical Tumor Who Presented with Persistently Elevated DHEAS after Bilateral Adrenalectomy
- Central Precocious Puberty Caused by Mutations in the Imprinted Gene MKRN3
- Frequency of molecular diagnosis in brazilian patients with 46,XY disorders of sexual development (DSD)
- Analysis of LH determination 2 hours after depot leuprolide acetate in monitoring gonadotropin-dependent precocious puberty treatment
- Two Kiss1 mutations associated with gonadotropin-dependent precocious puberty
- Paternally Inherited DLK1 Deletion Associated With Familial Central Precocious Puberty
- Anthropometric, metabolic and reproductive outcome of patients with central precocious puberty due to hypothalamic hamartoma in adult life
- Puberdade precoce central
Informações sobre o DOI: 10.1210/clinem/dgad028 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
